title: Targeting vascular endothelial growth factor in patients with squamous cell lung cancer.
authors.affiliation: Yale Comprehensive Cancer Center, Smilow Cancer Hospital at Yale-New Haven, Yale School of Medicine, New Haven, CT 06520-8028, USA.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Koo
authors.forename: Daniel
authors.initials: D
authors.lastname: Morgensztern
authors.forename: Julie L
authors.initials: JL
authors.lastname: Boyer
authors.forename: Roy S
authors.initials: RS
authors.lastname: Herbst
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism; D000077192:Adenocarcinoma of Lung; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000098:blood supply / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D015972:Gene Expression Regulation, Neoplastic; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008175:Lung Neoplasms / Q000098:blood supply / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011379:Prognosis; D040262:Receptors, Vascular Endothelial Growth Factor / Q000187:drug effects / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000187:drug effects / Q000378:metabolism*; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000378:metabolism; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism; D040321:Vascular Endothelial Growth Factor Receptor-3 / Q000378:metabolism
chemical_list: D020533:Angiogenesis Inhibitors; D014408:Biomarkers, Tumor; D042461:Vascular Endothelial Growth Factor A; D040262:Receptors, Vascular Endothelial Growth Factor; D040281:Vascular Endothelial Growth Factor Receptor-1; D040301:Vascular Endothelial Growth Factor Receptor-2; D040321:Vascular Endothelial Growth Factor Receptor-3